319 related articles for article (PubMed ID: 12385827)
1. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors.
Chapman SC; Bernard DJ; Jelen J; Woodruff TK
Mol Cell Endocrinol; 2002 Oct; 196(1-2):79-93. PubMed ID: 12385827
[TBL] [Abstract][Full Text] [Related]
2. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
3. Inhibin binding protein (InhBP/p120), betaglycan, and the continuing search for the inhibin receptor.
Bernard DJ; Chapman SC; Woodruff TK
Mol Endocrinol; 2002 Feb; 16(2):207-12. PubMed ID: 11818494
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
Ethier JF; Farnworth PG; Findlay JK; Ooi GT
Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
[TBL] [Abstract][Full Text] [Related]
5. Betaglycan localization in the female rat pituitary: implications for the regulation of follicle-stimulating hormone by inhibin.
Chapman SC; Woodruff TK
Endocrinology; 2003 Dec; 144(12):5640-9. PubMed ID: 14500575
[TBL] [Abstract][Full Text] [Related]
6. Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP).
Chapman SC; Woodruff TK
Mol Endocrinol; 2001 Apr; 15(4):668-79. PubMed ID: 11266516
[TBL] [Abstract][Full Text] [Related]
7. Inhibin B is a more potent suppressor of rat follicle-stimulating hormone release than inhibin a in vitro and in vivo.
Makanji Y; Temple-Smith PD; Walton KL; Harrison CA; Robertson DM
Endocrinology; 2009 Oct; 150(10):4784-93. PubMed ID: 19589860
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome.
Zhu R; Zhou X; Chen Y; Qiu C; Xu W; Shen Z
J Obstet Gynaecol Res; 2010 Feb; 36(1):138-46. PubMed ID: 20178540
[TBL] [Abstract][Full Text] [Related]
9. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
[TBL] [Abstract][Full Text] [Related]
10. Activins and inhibins and their signaling.
Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
[TBL] [Abstract][Full Text] [Related]
11. Inhibin is an antagonist of bone morphogenetic protein signaling.
Wiater E; Vale W
J Biol Chem; 2003 Mar; 278(10):7934-41. PubMed ID: 12493742
[TBL] [Abstract][Full Text] [Related]
12. Normal reproductive function in InhBP/p120-deficient mice.
Bernard DJ; Burns KH; Haupt B; Matzuk MM; Woodruff TK
Mol Cell Biol; 2003 Jul; 23(14):4882-91. PubMed ID: 12832474
[TBL] [Abstract][Full Text] [Related]
13. A Tale of Two Proteins: Betaglycan, IGSF1, and the Continuing Search for the Inhibin B Receptor.
Bernard DJ; Smith CL; Brûlé E
Trends Endocrinol Metab; 2020 Jan; 31(1):37-45. PubMed ID: 31648935
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and activin type-I and type-II receptors in preovulatory and prehierarchical follicles of the laying hen ovary.
Lovell TM; Knight PG; Gladwell RT
J Endocrinol; 2006 Feb; 188(2):241-9. PubMed ID: 16461550
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK
Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464
[TBL] [Abstract][Full Text] [Related]
16. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
Lovell TM; Knight PG; Gladwell RT
J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
[TBL] [Abstract][Full Text] [Related]
17. Gonadotrophins modulate hormone secretion and steady-state mRNA levels for activin receptors (type I, IIA, IIB) and inhibin co-receptor (betaglycan) in granulosa and theca cells from chicken prehierarchical and preovulatory follicles.
Lovell TM; Al-Musawi SL; Gladwell RT; Knight PG
Reproduction; 2007 Jun; 133(6):1159-68. PubMed ID: 17636170
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan-glycan.
Gray PC; Bilezikjian LM; Vale W
Mol Cell Endocrinol; 2001 Jun; 180(1-2):47-53. PubMed ID: 11451571
[TBL] [Abstract][Full Text] [Related]
19. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK
J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726
[TBL] [Abstract][Full Text] [Related]
20. Activin and inhibin receptor gene expression in the ewe pituitary throughout the oestrous cycle.
Fafioffe A; Ethier JF; Fontaine J; JeanPierre E; Taragnat C; Dupont J
J Endocrinol; 2004 Jul; 182(1):55-68. PubMed ID: 15225131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
